Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further reduce the number of injections in pediatric immunization schedules of countries currently using pentavalent DTaP combination vacc...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Nicola P. Klein, Remon Abu-Elyazeed, Brigitte Cheuvart, Winnie Janssens, Narcisa Mesaros
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2019-04-01
Edice:	Human Vaccines & Immunotherapeutics
Témata:	diphtheria tetanus acellular pertussis hepatitis b poliovirus haemophilus influenzae type b non-inferiority immunogenicity safety infants
On-line přístup:	http://dx.doi.org/10.1080/21645515.2018.1549449
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!